AUG 20, 2015 07:09 PM PDT

First FDA-Approved Sexual Enhancement Drug For Women

WRITTEN BY: Kara Marker
For years, males with sexual problems looking for a solution have had many drug treatments to choose from. For the first time, a drug claiming to fix female sexual problems has been approved by the Food and Drug Administration (FDA).

Drugs for men, like Viagra, do NOT instigate sexual arousal. Rather, they help produce the natural body chemicals that the man needs to obtain/maintain an erection when (already) sexually aroused. Men with erectile dysfunction have nervous system malfunctions, and the right amount of nitric oxide is not produced before or during sex. Normally, the nitric oxide stimulates production of cGMP. This enzyme then relaxes the smooth muscle cells of the penis, allows increased blood flow to the stimulated area, and subsequently produces and sustains an erection (British Pregnancy Advisory Service).  

Sexual problems in women are not as physically-oriented as the male problem described above. Women suffering from “Hypoactive Sexual Desire Disorder” (HSDD) report problems of not wanting sex in the first place, despite also reporting feelings of love and affection toward their partner. The FDA describes HSDD as “characterized by a deficiency or absence of sexual fantasies and desire for sexual activity which causes marked distress or interpersonal difficulty.”

Until now, no drug could be found on the market to treat HSDD. Flibanserin, produced by Sprout Pharmaceuticals, is the answer to the prayers of many sexually distressed women. After two rejections by the FDA, the pill was finally approved and will be available to purchase under the brand name “Addyi” starting October 17th (NPR).

Sprout Pharmaceuticals is known to be “committed to breakthrough firsts in women’s sexual health.” Sprout lists HSDD as affecting 10% of women in the United States. CEO Cindy Whitehead calls the authorization of flibanserin a time to “celebrate what this approval means for all women who have long awaited a medical treatment options for this life-impacting condition.”

Flibanserin is effective in treating HSDD in women by regulating the action of neurotransmitters. The drug is an agonist that restores natural release of neurons that fire and stimulate sexual arousal.

Many women are praising the opportunity to treat their sexual problems. A specific women’s health campaign called Even The Score, sponsored by Sprout Pharmaceuticals, released ads spoofing Viagra commercials and raising awareness for the need for a female sexual enhancement option. 

Not all women’s groups are excited about the pill, though. Cindy Pearson, National Women’s Health Network, is concerned about the “long-term effects of changing brain chemistry.” A report from CNN suggested a reason for the previous FDA rejections: “the modest benefit of the drug wasn’t worth potentially risky side effects including depression, but for some women struggling with desire, the hope for help is greater than the fear of side effects.”

Flibanserin cannot be taken with alcohol, and it’s not meant for post-menopausal women. When available in October, the drug will cost the same as Viagra. In addition, according to NPR, Sprout “hopes many insurance companies will cover the new drug to the same level they cover drugs like Viagra.”

Although the efficacy of flibanserin is under question, it still seems as if its approval is a ground-breaking move forward for women’s sexual health. The National Consumers League says the FDA approval of flibanserin “validates and legitimizes female sexuality as an important component of health.”

Come October, women will be able to see for themselves the impact of the drug in their lives. 

Check out the video below to learn more about the physiology of the sexual response in females and how it differs from the male sexual response.

Sources: Reuters, NPR, CNN
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
NOV 12, 2019
NOV 12, 2019
Parkinson's Disease is Present in the Blood
Parkinson's disease is a progressive disorder of the nervous system. Often starting with a barely noticeable tremor in one hand, the disease affects a...
NOV 12, 2019
Cannabis Sciences
NOV 12, 2019
Stages of Cannabis Plant Growth
What are the stages of cannabis plant growth?  As cannabis becomes more widely used both medicinally and recreationally, its legal cultivation is on t...
NOV 12, 2019
Earth & The Environment
NOV 12, 2019
Methylmercury levels rising with climate change
Researchers from the University of New Hampshire have recently published a study in the journal Geochemical Perspectives Letters detailing the consequences...
NOV 12, 2019
Health & Medicine
NOV 12, 2019
Screen Time Linked to Excess Sugar & Caffeine Intake in Teens
Adolescent screen-time is an intensely debated topic. New research from McMaster University has added more fuel to that fire and gives parents another reas...
NOV 12, 2019
Cannabis Sciences
NOV 12, 2019
U.S.A. Triathlon Makes Landmark Sponsorship Deal with CBD Company
U.S.A. Triathlon has just made a sponsorship deal with a company selling CBD products. This is a first for national governing bodies. Athletes, who often a...
NOV 12, 2019
Clinical & Molecular DX
NOV 12, 2019
Forecasting Chronic Pain
Chronic pain comes in many forms. Over half of those suffering from chronic pain, say they experience life-altering levels of pain on a daily basis. Many s...
Loading Comments...